Emerging trends in immunotherapy for pediatric sarcomas

While promising, immunotherapy has yet to be fully unlocked for the preponderance of cancers where conventional chemoradiation reigns. This remains particularly evident in pediatric sarcomas where standard of care has not appreciably changed in decades. Importantly, pediatric bone sarcomas, like ost...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyson, Kyle A., Stover, Brian D., Grippin, Adam, Mendez-Gomez, Hector R., Lagmay, Joanne, Mitchell, Duane A., Sayour, Elias J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636007/
https://www.ncbi.nlm.nih.gov/pubmed/31311607
http://dx.doi.org/10.1186/s13045-019-0756-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636007/
https://www.ncbi.nlm.nih.gov/pubmed/31311607
http://dx.doi.org/10.1186/s13045-019-0756-z

Ejemplares similares